Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy

AIDS. 2003 Jan 3;17(1):121-3. doi: 10.1097/00002030-200301030-00017.

Authors

David Nolan¹, Corey Moore, Alison Castley, David Sayer, Cyril Mamotte, Mina John, Ian James, Simon Mallal

Affiliation

¹ Centre for Clinical Immunology and Biomedical Statistics, and Department of Clinical Immunology and Biochemical Genetics, Royal Perth Hospital, Perth, Western Australia.

PMID: 12478078
DOI: 10.1097/00002030-200301030-00017

No abstract available

MeSH terms

Antiretroviral Therapy, Highly Active / adverse effects
Cohort Studies
Disease Progression
Genetic Predisposition to Disease*
HIV-Associated Lipodystrophy Syndrome / genetics*
Humans
Polymorphism, Genetic*
Promoter Regions, Genetic / genetics
Proportional Hazards Models
Risk Factors
Time Factors
Tumor Necrosis Factor-alpha / genetics*

Substances

Tumor Necrosis Factor-alpha